Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
Covington
AstraZeneca
Julphar
Cerilliant
Express Scripts
US Army
US Department of Justice

Generated: June 19, 2018

DrugPatentWatch Database Preview

PROLIXIN DECANOATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Prolixin Decanoate, and when can generic versions of Prolixin Decanoate launch?

Prolixin Decanoate is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in PROLIXIN DECANOATE is fluphenazine decanoate. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
Summary for PROLIXIN DECANOATE
Drug patent expirations by year for PROLIXIN DECANOATE
Synonyms for PROLIXIN DECANOATE
002F471
2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethyl decanoate
2-(4-(3-(2-(Trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl decanoate
2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethyl decanoate
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
4,4-difluoro-N-((S)-3-(3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-aza-bicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
5002-47-1
AC1L1FTN
AC1Q4K03
AK398551
AKOS003589045
AN-19944
AS-11646
BRN 0599852
C07956
C32H44F3N3O2S
CCRIS 3954
CHEMBL1200854
CTK8F9823
D00793
D03NTJ
Dapotum D
Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
Decanoic acid, 2-[4-[3-[2-(trifluoromethyl) -10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
DTXSID7023069
EINECS 225-672-4
Flufenazine decanoate
Fluorophenazine decanoate
Fluphenaline decanoate
Fluphenazine decanoate
Fluphenazine decanoate (JAN/USP)
Fluphenazine decanoate [USP:BAN:JAN]
Fluphenazine depot
Fluphenazine O-decanoate
Fluphenazinedecanoate
FMU62K1L3C
LP016893
LS-59383
MLS006010097
Modecate
Moditen depot
Moditen-depo
MolPort-001-728-034
NSC 169510
NSC-169510
NSC169510
Prolixin decanoate (TN)
SCHEMBL41288
SMR004701239
SQ 10,733
UNII-FMU62K1L3C
WLN: T C666 BN ISJ EXFFF B3- AT6N DNTJ D2OV9
ZINC22816725

US Patents and Regulatory Information for PROLIXIN DECANOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PROLIXIN DECANOATE fluphenazine decanoate INJECTABLE;INJECTION 016727-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
US Department of Justice
McKesson
Cipla
Farmers Insurance
Baxter
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.